We thank the CDC of Taiwan for providing the W135 bacteria strain. This work was supported by Academia Sinica and National Science Council, Taiwan. (Grant no NSC 99-2113M-001-008-MY2 and NSC 101-2628M-001-004-MY2 to C.-Y.W.)
Synthesis of Neisseria meningitidis Serogroup W135 Capsular Oligosaccharides for Immunogenicity Comparison and Vaccine Development†
Version of Record online: 10 JUL 2013
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Angewandte Chemie International Edition
Volume 52, Issue 35, pages 9157–9161, August 26, 2013
How to Cite
Wang, C.-H., Li, S.-T., Lin, T.-L., Cheng, Y.-Y., Sun, T.-H., Wang, J.-T., Cheng, T.-J. R., Mong, K. K. T., Wong, C.-H. and Wu, C.-Y. (2013), Synthesis of Neisseria meningitidis Serogroup W135 Capsular Oligosaccharides for Immunogenicity Comparison and Vaccine Development. Angew. Chem. Int. Ed., 52: 9157–9161. doi: 10.1002/anie.201302540
- Issue online: 22 AUG 2013
- Version of Record online: 10 JUL 2013
- Manuscript Revised: 11 JUN 2013
- Manuscript Received: 26 MAR 2013
- Academia Sinica
- National Science Council, Taiwan. Grant Numbers: NSC 99-2113M-001-008-MY2, NSC 101-2628M-001-004-MY2
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.